advertisement

Topcon

Abstract #52406 Published in IGR 15-1

Surgical Outcome of Mitomycin C-soaked Collagen Matrix Implant in Trabeculectomy

Min JK; Kee CW; Sohn SW; Lee HJ; Woo JM; Yim JH
Journal of Glaucoma 2013; 22: 456-462


PURPOSE: To assess the surgical outcomes and wound healing reaction of a filtering bleb after trabeculectomy using mitomycin C-soaked biodegradable collagen matrix (ologen). METHODS: Thirty eyes, in which the intraocular pressure (IOP) could not be controlled within the proper range by medication or laser treatment, were targeted in this study. After trabeculectomy with mitomycin C (0.2 mg/mL, 0.1 mL)-soaked ologen, surgical outcomes were assessed by evaluating bleb morphology by the Moorfield bleb grading system, as well as internal reflectivity and wound healing response of the bleb using a slit lamp and ultrasound biomicroscopy. The follow-up period continued for 12 months after surgery. RESULTS: Twelve months after surgery, 12/30 (40.0%) eyes were considered complete successes and 24/30 (80%) eyes as qualified successes. This rate is similar to the rate of our conventional trabeculectomy. The encapsulated bleb was the most frequent complication (9 eyes) and generally occurred at approximately 2 weeks after surgery. No avascular blebs were observed at final follow-up. CONCLUSIONS: Trabeculectomy with mitomycin C-soaked ologen do not seem to exert any synergistic effect with antimetabolites in terms of a reduction in IOP. However, the mitomycin C-soaked collagen matrix implant used in trabeculectomy resulted in comparatively stable IOP and did not aggravate wound healing or scar formation. Encapsulated blebs were generated at a more rapid pace in larger amounts compared with conventional trabeculectomy. The management of encapsulated blebs may be crucial to improving the success rate of surgery.

*Department of Ophthalmology, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan ‡Department of Ophthalmology, Gangneung Asan Hospital, Ulsan University College of Medicine, Gangneung †Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine §Department of Ophthalmology, Eulji General Hospital, Eulji University School of Medicine, Seoul, Republic of Korea.

Full article

Classification:

12.8.10 Woundhealing antifibrosis (Part of: 12 Surgical treatment > 12.8 Filtering surgery)



Issue 15-1

Change Issue


advertisement

Oculus